Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer (Q28266601)

2

0 references

P Guo

3

0 references

X-Y Dong

4

0 references

P Sethi

5

0 references

W Zhou

6

0 references

Z Zhou

7

0 references

J Petros

8

0 references

H F Frierson

9

0 references

R L Vessella

10

0 references

A Atfi

11

0 references

J-T Dong

A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer

12

0 references

language of work or name

English

0 references

publication date

5 April 2007

0 references

published in

Oncogene

0 references

volume

26

0 references

issue

16

0 references

page(s)

2386-94

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Deletion, mutation, and loss of expression of KLF6 in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Prevalent mutations in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Alternative splicing determines the domain structure of WWP1, a Nedd4 family protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Reg IV: a promising marker of hormone refractory metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Abnormal expression of MDM2 in prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Genetic alterations in hormone-refractory recurrent prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Mechanisms underlying ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

The two faces of transforming growth factor beta in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

WWP1-dependent ubiquitination and degradation of the lung Krüppel-like factor, KLF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021

Differential expression and localisation of WWP1, a Nedd4-like protein, in epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210021